Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 27th February 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Norbrook Laboratories Ltd issues recall of anaesthetic
product recall
The affected UK brand names are Inductofol (licence no: 02000/4274) and Vetofol (licence no: 02000/4244).
Coring issue reported for Propofol Emulsion for injection
 
Wholesalers and veterinary surgeons are being made aware of a product defect recall for Propofol Emulsion for Injection, which is manufactured by Norbrook Laboratories Ltd.

All batches of Propofol Emulsion for Injection 1.0% w/v that are currently on the market are being recalled, due to an issue of coring.

In a statement, the Veterinary Medicines Directorate (VMD) said: ‘An issue of coring has been reported, where the shearing off of a portion of the 20mm bromobutyl bung occurs as the vial is pierced to withdraw the product. This may result in particles from the bung entering the product and potentially being drawn up into the syringe upon extraction of the product from the vial. It may also result in the bung not resealing fully after use.’

The affected UK brand names are Inductofol (licence no: 02000/4274) and Vetofol (licence no: 02000/4244).

For further information contact Mrs Deborah Curran on 028 3026 4435 or email deborah.curran@norbrook.co.uk

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'